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Abstract
It is now established that, as compared to normal cells, the cancer cell genome has an overall inverse distribution of DNA
methylation (‘‘methylome’’), i.e., predominant hypomethylation and localized hypermethylation, within ‘‘CpG islands’’ (CGIs).
Moreover, although cancer cells have reduced methylation ‘‘fidelity’’ and genomic instability, accurate maintenance of
aberrant methylomes that underlie malignant phenotypes remains necessary. However, the mechanism(s) of cancer
methylome maintenance remains largely unknown. Here, we assessed CGI methylation patterns propagated over 1, 3, and 5
divisions of A2780 ovarian cancer cells, concurrent with exposure to the DNA cross-linking chemotherapeutic cisplatin, and
observed cell generation-successive increases in total hyper- and hypo-methylated CGIs. Empirical Bayesian modeling
revealed five distinct modes of methylation propagation: (1) heritable (i.e., unchanged) high- methylation (1186 probe loci in
CGI microarray); (2) heritable (i.e., unchanged) low-methylation (286 loci); (3) stochastic hypermethylation (i.e., progressively
increased, 243 loci); (4) stochastic hypomethylation (i.e., progressively decreased, 247 loci); and (5) considerable ‘‘random’’
methylation (582 loci). These results support a ‘‘stochastic model’’ of DNA methylation equilibrium deriving from the
efficiency of two distinct processes, methylation maintenance and de novo methylation. A role for cis-regulatory elements in
methylation fidelity was also demonstrated by highly significant (p,2.2610
25) enrichment of transcription factor binding
sites in CGI probe loci showing heritably high (118 elements) and low (47 elements) methylation, and also in loci
demonstrating stochastic hyper-(30 elements) and hypo-(31 elements) methylation. Notably, loci having ‘‘random’’
methylation heritability displayed nearly no enrichment. These results demonstrate an influence of cis-regulatory elements
on the nonrandom propagation of both strictly heritable and stochastically heritable CGIs.
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Introduction
DNA methylation is a vital vertebrate animal process
intimately linked to the proper regulation of gene expression
and the preservation of genomic integrity. In non-embryonic
cells, DNA methylation predominantly occurs at the C5 position
of cytosines 59 to adjacent guanines (i.e., transpiring within
‘‘CpG’’ dyads) [1,2]. In concert with other epigenetic (i.e.,D N A
sequence-external) events, DNA methylation is one of the
primary mediators of cellular lineage commitment and tissue-
specific specialization during organismal development [3,4]. In
addition to differentiation, DNA methylation also suppresses the
expression/transposition of (potentially mutagenic) repetitive
elements, maintains heterochromatinization within satellite
DNA (thus facilitating genomic stability), and silences the
monoalleles of imprinted genes and the inactive X chromosome,
within female somatic cells.
Due to its crucial role in the development and maintenance of
differentiated phenotypes, DNA methylation patterns must be
precisely replicated during DNA synthesis and cell division. DNA
methylation is catalyzed by DNA methyltransferases (DNMTs), of
which three active isoforms exist in mammals: DNMT-1, DNMT-
3a, and DNMT-3b [1,2,5]. Of these, the ‘‘maintenance’’
methyltransferase, DNMT1, associates with the DNA replication
machinery (‘‘replisome’’) during DNA synthesis and (similar to
DNA polymerase-1) is believed to utilize the template strand
(‘‘hemimethylated,’’ or already methylated from the previous cell
division) to correctly transfer methyl groups to deoxy-cytosines
within the nascent DNA molecule [6,7,8]. A current model of
DNA methylation posits that DNMT1 acts in a processive,
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32928stochastic manner, methylating the new DNA strand in cooper-
ation with the de novo DNMTs 3a and 3b, resulting in the very
accurate (.99.5%) [9,10] maintenance of regional DNA methyl-
ation levels, without necessarily exact copying of specific
methylcytosines [6,9,11,12].
While over 80% of all genomic CpG dinucleotides are
methylated in somatic cells, distinct CpG-rich regions (‘‘CpG
islands,’’ CGIs), often associated with gene promoters, remain
largely (.70%) unmethylated [1,13,14,15]. CGIs frequently
colocalize with essential cis-acting DNA elements, including origins
of replication, regions of nucleosome depletion [15,16], and our
group [17,18] and others [15,19,20,21] have also demonstrated
CGIs are enriched with transcription factor binding sites (TFBSs).
How hypomethylated CGIs are ‘‘protected’’ from methylation is
not well understood, but in addition to transcription, is believed to
involve zinc-finger proteins possessing a CXXC motif for binding
unmethylated CpG-rich sequences [16,22,23] that modify chro-
matin/histones into an ‘‘open,’’ transcriptionally permissive
conformation [1,2]. Likewise, ‘‘insulator’’ DNA-binding proteins
have been shown to protect specific active transcriptional modules
from DNA methylation and other gene-repressive chromatin
modifications [24].
Another possible mechanism of ‘‘protecting’’ CGIs from DNA
methylation is via transcription factor recruitment of gene-
activating chromatin modifiers (e.g., coactivators such as histone
acetyltransferases) that also facilitate decondensation of chromatin
[1]. Furthermore, in some active genes, the transcriptional
machinery may sterically obstruct promoter-associated CGIs from
repressive, DNMT-containing complexes, and our group [25] and
others [13,15,20,21] have also shown that silencing of some
transcription factors may result in promoter DNA methylation of
their downstream ‘‘target’’ genes. However, a large number of
silenced genes also remain methylation-free, demonstrating that
transcription-associated steric obstruction of DNMTs is but one of
several bases for preserving CGI hypomethylation [13,15]. By
contrast, some transcription factors may actually direct gene
repression, by recruiting DNMTs 3A and/or 3B for the
methylation of specific target genes [26].
Although copying of DNA methylation patterns is very precise
in normal cells, the accumulation of methylation errors (e.g.,a s
occurs during aging, various environmental exposures, or
dysregulation of chromatin modifiers) can spur the onset of
several diseases, including cancer and various developmental,
autoimmune, and neurological disorders [2,27]. Cancer cells in
particular, as compared to normal cells, have an overall inverse
distribution of genomic DNA methylation, i.e., global hypomethy-
lation and localized hypermethylation (within CGIs) [1,2]. It has
also been demonstrated that cancer cells often possess decreased
methylation fidelity, partially associated with increased de novo
methylation and genomic instability [2,5,11,28,29,30,31]. None-
theless, despite those many impediments, accurate maintenance of
cancer-associated methylation patterns is necessary for the
‘‘memory’’ of gene expression patterns that preserve a tumor-
progressive phenotype (thus facilitating growth-advantaged clonal
expansion and/or the sustainment of ‘‘cancer stem cells’’) [23,32].
Further corroboration for a requirement of DNA methylation
maintenance in neoplasia is provided by the finding that DNMT1
knockdown is lethal to transformed cells [33]. However, while a
model for DNA methylation fidelity in normal cells is now well
supported, the mechanism(s) that preserves tumor-associated
methylation patterns, in cancer cells, remains for the most part,
unknown.
Based on those previous DNA methylation studies, we deter-
mined the DNAmethylation levels[34,35] of over 44,000CpG-rich
oligonucleotides, derived from 12,000 genes, over the course of 1, 3,
and 5 cell generations of A2780 ovarian cancer cells. Our overall
objective was to examine the fidelity of DNA methylation
heritability even in the presence of multiple negative effectors of
faithful methylation inheritance, including DNA damage and two
cancer cell phenotypes, accelerated cell growth and possible
aberrant expression of chromatin-modifying genes [36,37]. If such
fidelity was indeed observed, a secondary objective was to begin to
investigate a possible basis(es) for the maintenance of faithful
methylation heritability. Those findings demonstrated both strict
(unchanged) and stochastic (i.e., fluctuating) methylation heritability
patterns over the five cell generations, and the validity of those
methylation measurements was also substantiated using multiple,
highly accurate normalization procedures. Further, we observed a
substantial amount of ‘‘random’’ transgenerational methylation, as
might be expected, in DNA-damaged and genetically unstable
cancer cells (which already possess the methylation heritability
impediments described above) [5,29,31,32,38]. We also observed
that both stochastically and strictly heritable CGIs were highly
enriched with transcription factor binding sites (TFBSs), with
significant TFBS overlap between parental cell CGI probe loci
having similar starting levels of DNA methylation. Randomly
propagated CGIs, however, were devoid of such cis-regulatory sites,
raising the possibility of a biological mechanism(s) that preferentially
enforces methylation fidelity within CpG-dense DNA regions
having cis-regulatory elements, as compared to regions lacking such
elements, during the process of tumor progression.
Results
Global DNA methylation levels after 1, 3, and 5 cell
generations, concordant with cisplatin exposure
We examined transgenerational heritability patterns of faithful
DNA methylation maintenance in the ovarian cancer cell line
A2780, over the course of 1, 3, and 5 cell divisions, concordant
with exposure to a number of variables that might negatively affect
DNA methylation fidelity, including DNA damage, accelerated
cell division (and thus DNA synthesis), and altered expression of
chromatin modifiers.
When comparing CGI methylation profiles of first, third, and
fifth generation cells, vs. their parental A2780 cells, we observed
substantial, progressive increases in both hypermethylated, and
hypomethylated CGI probe loci for the three cell generations,
coexistent with numerous loci exhibiting no change in DNA
methylation (Figures 1 and 2). Despite those considerable changes
in DNA methylation, the overall methylation distributions, across
generations-1, 3, and 5 were similar (Figure 1), with the
methylation status of any specific gene estimated by its probability
of differential methylation determined by our previous empirical
Bayesian model [39], and a probability threshold of 0.80 (See
Methods). At that threshold, the proportions of differentially
methylated CGI probe loci, as compared to the total number of
CGI probe loci, were 0.0154, 0.033, and 0.062 for cell generations
1, 3, and 5, respectively (Figure 2A). We observed progressive and
substantial increases in both hypomethylated (85, 448, 1191) and
hypermethylated (442, 673, 904) CGI probe loci for generations 1,
3, and 5, respectively (Figure 2B). As shown, 1
st generation cells
possessed about 49% of the CGI probe loci found hypermethy-
lated in 5
th generation cells, but less than 10% of the loci found
hypomethylated in 5
th generation cells, thus demonstrating a
greater rate (about 6 times larger) of hypomethylation than
hypermethylation following repeated cell division and DNA
damage, similar to previous studies of prostate cancer and other
solid tumors [40,41].
cis-Regulation on DNA Mthylation Fidelity
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assessment of generation-3 A2780 daughter cells
To substantiate our two-color DNA methylation microarray
results, in addition to using standard normalization, we addition-
ally performed a superior technique for validating lack of
systematic errors. This control validation entails using the identical
experimental procedure, with the sole deviation being a ‘‘dye
swap,’’ i.e., using Cy5 (red, in place of Cy3, green) for labeling of
the parental cells, and using Cy3 in place of Cy5 for the various
generation daughter cells. As shown in Figure 3, the correlation
between the swap dyes and non-swap dyes were 0.934 for the
generation-3 cells and 0.926 for the parental cells, before Loess
Figure 1. Scatter plots of differential DNA methylation for A2780 cells after 1, 3, and 5 cell generations, coincident with cisplatin
DNA crosslinking. The log signals of average observed methylation signals of the parent A2780 cells (x-axis) were compared to the log signals of
observed methylation in (A) generation-1; (B) generation-3, and (C) generation-5 cells, respectively. Red represents the hyper methylated CGI probe
loci, blue represents the hypo methylated CGI probe loci, and green represents not differentially methylated CGI probe loci.
doi:10.1371/journal.pone.0032928.g001
Figure 2. Analysis statistics of differential DNA methylation. (A) Percentages of differentially methylated CGI microarray probes identified by
empirical Bayesian model (probability$0.8) between A2780 cells (baseline) and progeny cell generations 1, 3, and 5 (also treated with the DNA
crosslinker cisplatin). Decreased or increased methylation levels from baseline parental cells to progeny cells were defined as the differential
methylation; (B) Number of hypomethylated (decreased methylation) and hypermethylated (increased methylation) microarray CGI probes for the
cell generations 1, 3, and 5, as compared to the parental cells.
doi:10.1371/journal.pone.0032928.g002
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tively. These strong correlations indicate that the methylation
signals detected by the microarrays were reproducible, and free of
various systematic errors that can confound accurate detection of
intensity differences [42]. In the follow-up analysis, we used the
average methylation signals of two generation 3 microarray
replicates.
Cell generation-dependent DNA methylation reveals five
distinct categories of the propagation of CGI DNA
methylation
A current, widely accepted mechanism of DNA methylation
maintenance, which has been well validated experimentally
[6,7,43], is the ‘‘stochastic’’ methylation model, which sets forth
that the average methylation levels of specific regions result from
the efficiency of two cooperative stochastic processes: heritable
maintenance methylation and de novo methylation, occurring in
concert with DNA replication [8,11,12,44,45]. In this study, we
further subcategorized strictly heritable methylation into two
classes, heritable high and heritable low methylation; and two
subclasses showing progressive fluctuation, stochastic hypermethylation
and stochastic hypomethylation (Table 1). In addition, we also observed
methylated loci showing neither heritable nor stochastic DNA
methylation; those particular loci were categorized into a fifth
class, random methylation, defined as loci having transgenerational
methylation propagation inconsistent with existing (stochastic or
heritable) methylation models [11,12,44].
Figure 3. Correlation of DNA methylation intensities between the swap and non-swap microarrays of generation 3 cells. (A) and (B)
are scatter plots and correlations of parental and cisplatin treated cells before normalization, respectively. (C) and (D) are scatter plots and correlations
of parental and cisplatin treated cells after normalization, respectively.
doi:10.1371/journal.pone.0032928.g003
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classified generation-dependent methylation propagation patterns
of A2780 cell generations (coincident with enhanced resistance to
cisplatin) [46,47]. As shown in Figure 4, the propagation of CGI
methylation patterns in progeny (1
st,3
rd,5
th generations) cells, as
compared to the parental cells, fell into the five abovementioned
categories (also see Table 1 and Methods): 1) heritable high
methylation (1186 CGI probe loci); 2) heritable low methylation
(286 loci); 3) stochastic hypermethylation (243 loci); 4) stochastic
hypomethylation (247 loci); and 5) random methylation (defined
above, 582 loci) (Figure 4 and Table 2). While these findings are
consistent with both the heritable and stochastic models of DNA
methylation maintenance [11,12], they also demonstrate a
significant degree of random (i.e., indiscriminate) propagation of
CGI loci methylation that might occur following various biological
insults [48]. These results, especially random methylation,
demonstrate that within any specific cell population, DNA
methylation can vary across the genome, in close agreement with
a recent study of methylation ‘‘entropy’’ [45].
Since our methylation microarray possess over 40,000 60-mer
probes, derived from ,12,000 genes, many genes possessed .1
probes. Consequently, to assess whether probe loci residing within
the same CpG island segregated into the same DNA methylation
heritability categories, we performed an extended analysis by
placing intra-CGI probes into clusters and analyzing the possible
DNA methylation heritability categories of probes in each cluster
(See Methods). Those results showed that, with the exception of
probe loci belonging to the ‘‘heritable methylation’’, the majority
of CpG island-colocalized probes did not similarly categorize with
one another (data not shown). While this limited analysis precludes
any strong inferences from these results, we speculate that the
fidelity of DNA methylation could differ between specific
subregions within the same CGI, and we could speculate that
those better-maintained methylation sequences could also associ-
ate with cis-regulatory elements, with such elements not associated
to adjacent CGI probe loci.
Extent of TFBS enrichment in CGIs displaying the five
categories of propagation of DNA methylation
Based on previous studies demonstrating CGI are enriched with
transcription factor binding sites [14,15,18,19,20,49,50], the
stochastic model of methylation inheritance [11,12,44,51,52],
and the necessity of accurate methylation heritability for sustaining
cancer phenotypes [23,32], we assessed the possible influence of
cis-regulatory DNA elements on DNA methylation fidelity over the
course of the five cell generations. Using our published bioinfor-
matics algorithm [18], we assessed TFBS enrichment within CGI
probe loci segregating into the five methylation maintenance
categories listed in Table 1. To assess the specificity of TFBS
enrichment to CGI probe loci, two distinct sets of background
sequences were also examined for TFBS motifs, with each set
having identical GC content and sequence length (see Methods).
Both sets of background sequences yielded very similar TFBS
enrichment analysis (Table 2), thus validating our background
sequence selection (length and GC content-matched). The
numbers of enriched TFBSs for CGI probe loci within each
Table 1. Categorization of CGI probe loci into five distinct classes of DNA methylation propagation.
Categories Differential Methylation
Parental vs. Generation-1 Cells Parental vs. Generation-3 Cells Parental vs. Generation-5 Cells
Stochastic Hypomethylation down down down
even down down
even even down
Stochastic Hypermethylation up up up
even up up
even even up
Random Methylation down up down
down up even
down even down
even up down
even up even
even down even
even down up
up down up
up down even
up even up
Heritable Low Methylation even even even
Heritable High Methylation even even even
To determine transgenerational DNA methylation fidelity, methylation levels of specific microarray CGI loci were examined after 1, 3, and 5 cell divisions of the (parental)
ovarian cancer cell line A2780. CGI probe loci showing generation-dependent, progressively increased methylation from generations 1 to 5, were defined as the
stochastically hypermethylated, while CGI loci showing progressively decreased methylation were considered ‘‘stochastically hypomethylated.’’ Microarray CpG loci
demonstrating a mixture of increased and decreased methylation from generations 1 to 5 were considered ‘‘randomly methylate,’’ while CGI loci showing consistently
high methylation (.85% of the maximal microarray fluorescence, regardless of generation, also having #15% changes between generations) were designated as
‘‘heritably highly methylated.’’ Finally, loci consistently having ,15% of the maximal fluorescence (regardless of cell generation, also having #15% changes between
generations) were categorized as being ‘‘heritably lowly methylated.’’
doi:10.1371/journal.pone.0032928.t001
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promoter sequences as background were as follows: heritable
highly methylated loci, 118 TFBSs; heritable lowly methylated
loci, 47; stochastically hypermethylated loci, 30; and stochastically
hypomethylated loci, 31 (again consistent with the hallmark of
extensive CGI hypermethylation in cancer cells) [2,27,32]
(Table 2). Strikingly, we found nearly no TFBS enrichment in
CGI probe loci demonstrating random methylation across the
three cell generations (Table 2). While this result could have
multiple interpretations, one possibility is a reduced stringency of
methylation fidelity within CGI probe loci unassociated with cis-
acting regulatory elements.
Based on prior studies demonstrating CGI association with
various essential cis-acting DNA elements [13,15], we next
examined the possible influence of TFBSs on the fidelity of CGI
propagation. We first compared TFBS enrichment within loci
possessing similar initial methylation levels in the parental cells.
For example, between TFBSs enriched in stochastically hypo-
methylated and heritable highly methylated CGI probe loci (i.e.,
both loci sets being initially significantly methylated in the parental
cells), we observed 28 TFBSs in common (Figure 5A). Similarly, 19
of 30 TFBSs enriched in stochastically hypermethylated loci were
also present in heritable lowly methylated CGI probe loci,
consistent with both sets starting with relatively low methylation
(Figure 5B). Likewise, in heritability categories with dissimilar
starting levels of methylation in the parental cells, we observed no
overlap in TFBS enrichment, i.e., between heritably highly and
heritably lowly methylated CGI probe loci, and between
stochastically hypomethylated and stochastically hypermethylated
CGI probe loci (Figures 5C and 5D). These results are consistent
with the stochastic DNA methylation maintenance model, which
describes equilibration of DNA methylation, at specific loci, is a
function of the methylation efficiencies of methylation mainte-
nance (by DNMT1) and de novo methylation, catalyzed by
DNMTs,
To further examine the TFBS commonalities between the
various overlapping methylation propagation categories, we
assessed possible biological functions of their cognate transcription
factors (TFs), with specific regard to cancer relatedness and cell
cycle progression. TFs corresponding to the TFBSs found
enriched within CGIs having steady or high starting methylation
levels (i.e., stochastically hypomethylated and heritable highly
Figure 4. Heatmap and CGI probe loci distributions of the five categories of methylation pattern maintenance. The normalized
methylation signals for loci in five different methylation patterns were compared, ranging as vertically Parental replicate dyes and generation 1, 3, 5
cisplatin treated dyes, and horizontally heritable high methylation (1186 CGI loci), heritable low methylation (286 loci), random methylation (582 loci),
stochastic hypermethylation (243 loci), and stochastic hypomethylation (247 CGI loci). ‘‘parental rep 2’’ indicates the average of parental dyes of non-
swap and swap microarray experiments, while ‘‘gene-3 cells’’ is the average of corresponding generation 3 dyes.
doi:10.1371/journal.pone.0032928.g004
Table 2. TFBS enrichment in CGI probe loci segregating into each of the five methylation propagation categories.
Category Probe Sequences
Enriched TFBSs Using
Background Sequence Set #1
a
(p,2.2*e-5)
Enriched TFBSs Using
Background Sequence Set #2
b
(p,2.2*e-5)
Stochastic Hypomethylation 247 31 18
Stochastic
Hypermethylation
243 30 28
Random
Methylation
582 1 0
Heritable
Low Methylation
286 47 19
Heritable
High Methylation
1186 118 115
TFBS frequencies were compared between each of the five sets of probe sequences separately from five methylation categories and the background sequences
through Fisher exact test. Two different background sequences sets were used, as described above and in the text, to examine the specificity of TFBS enrichment to the
CGI probe loci categorized into the five methylation maintenance categories. The p-value threshold was justified by a factor of 45965, i.e. 0.05/459/5=2.2610
25, based
on 459 TFBS motifs and 5 comparisons.
aBackground Sequence Set #1 = randomly generated promoter sequences (length/%GC-matched) to the CGI probe loci categorized into the five methylation classes.
bBackground Sequence Set #2 = randomly selected microarray probe sequences (length/%GC-matched) uncategorized into the five methylation classes.
doi:10.1371/journal.pone.0032928.t002
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differentiation (myogenic factors, including MYOD1, MYOG,
MYF5, and MYF6), RAR family genes (encoding mediators of
differentiation of multiple tissue stem cells), oxidative response
genes (NFE2, NFE2L2), and tumor suppressors often downregu-
lated by DNA methylation in various cancers, including TFAP2A,
TFAP2B, and TFAP2C (Table 3). While enhanced methylation
(and in likelihood, transcription silencing) of these differentiation-
associated genes is consistent with the cancer phenotype, we also
observed several proto-oncogenic TFs in this group, including
MYC and TCF, PAX, and RUNX family genes. By contrast, in
CGIs with steady or initially low DNA methylation (i.e.,
stochastically hypermethylated and heritable lowly methylated
loci), overlapping TFBSs included those associated with cancer
promotion, including various proto-oncogenes such as the HMG,
STAT, and NKX families (Table 3), again consistent with the
malignant phenotype. However, similar to the enhanced methyl-
ation category, we also (paradoxically) observed low methylation
of some tumor suppressors, including the ONECUT and FOX
(forkhead) family of TF genes. These results suggest that the
maintenance of DNA methylation levels of TFBSs may only
partially relate to their associated biological functions (upon
binding their cognate TFs), and might also be influenced by the
mere presence of specific cis-acting elements themselves.
Evaluation of regulators of DNA methylation that might
contribute to ‘‘random’’ methylation
While the predominant finding of this study was that cis-acting
DNA regulatory elements associate with non-random heritable
DNA methylation patterns, we also identified a substantial number
of loci showing no generational trends of DNA methylation
inheritance, in noncompliance with the stochastic methylation
maintenance model of Riggs et al. [11,12,44]. While extensive
examination of mechanisms of such methylation ‘‘randomness’’
was beyond the scope of this study, we nonetheless identified
various factors that could likely contribute to this (seemingly)
disordered methylation patterning.
We assessed the expression of a number of genes encoding
chromatin-modifying proteins that could potentially facilitate
‘‘random’’ DNA methylation (Table 4). Alterations in the
expression of chromatin modifiers that might decrease DNA
methylation included downregulation of genes encoding histone
acetyltransferases (MYST3 and MYST4), while gene expression
changes that might increase random DNA methylation [24,53]
included downregulation of the DNA-methylation ‘‘insulator’’
gene, CTCF, upregulation of the de novo DNA methyltransferase
DNMT3B gene, and upregulation of the CTCF-antagonist gene
CTCFL (BORIS) [38,54,55]. Random de novo DNA methylation
also occurs via DNMT recruitment to DNA repair complexes at
sites of single- or double-strand breaks, which can result from
DNA stand crosslinking by platinum drugs such as cisplatin (as
used in this study) [29,31,56]. Taken together, we observed greater
gene expression dysregulation that would tend to associate with
increased, cis-regulatory element-independent (and perhaps, DNA
replication-independent) DNA methylation, as compared to gene
expression alterations facilitating decreased DNA methylation,
although more extensive laboratory validation is required to
substantiate this conjecture.
Discussion
In this study, we used a microarray approach [34,35,57] for
examining DNA methylation inheritance over five generations of
the chemotherapy-sensitive ovarian cancer cell line A2780 [46],
hypothesizing that some DNA-methylated loci might demonstrate
reproducible DNA methylation heritability, despite the presence of
various phenomena that might oppose such reproducibility. While
Figure 5. Overlaps of enriched TFBSs among CGI probe loci segregating into the four methylation categories. (A) Overlap between
enriched TFBSs in stochastically hypomethylated CGI probe loci and in heritably highly methylated CGI probe loci; (B) Overlap between enriched
TFBSs in stochastically hypermethylated CGI probe loci and heritably lowly methylated CGI probe loci; (C) Overlap between enriched TFBSs in
heritably lowly methylated CGI probe loci and heritably highly methylated CGI probe loci; and (D) Overlap between enriched TFBSs in stochastically
hypomethylated CGI probe loci and stochastically hypermethylated CGI probe loci.
doi:10.1371/journal.pone.0032928.g005
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of methylated sequences with very high accuracy (as we observed
in our highly and lowly heritably methylated CGI probe loci), it
also provides for dynamic fluctuations that may, over time, result
in the partial or complete loss of DNA methylation [11,12]. In
their seminal publication, Riggs et al. computationally predicted
that from a cell population having an average of 50% methylation
at any specific CpG dyad, the selection of two clones having 0%
and 100% DNA methylation levels would, after approximately 30
generations, equilibrate to a steady state of 50% methylation at
that particular dyad; that computational prediction was in large
agreement with independent, experimental validation studies
[6,43,52,58]. As our cell generational studies were initiated with
a single clone of the parental A2780 cells, we assert that specific
CpG loci could likewise demonstrate progressive increases or
decreases in DNA methylation, with an eventual equilibrium after
30 or more cell generations. As we examined DNA methylation
after only the 1
st,3
rd, and 5
th generations, such progressive
methylation increases or decreases should still be occurring. Thus,
for specific subpopulations of loci possessing high or low
methylation levels and derived from a heterogeneously methylated
cell population, our data is quite consistent with the stochastic
model [11,12].
The Riggs’ stochastic model further predicts that starting from a
mixed population, the propagation of CGI probe loci categorized
as stochastic hypomethylation could exhibit an increase in failed
methylation maintenance and/or an inadequate low rate of de novo
methylation, while stochastically hypermethylated loci, also within
an initially clonal population, might possess an increased rate of de
novo methylation [20,32], perhaps mediated by transcription factor
recruitment of epigenetically repressive complexes to target genes
[26]. In addition, our data suggests that distinct groups of TFs
associate with high (e.g., myogenic TFs) or low (POUF TF family
genes) strictly heritable CGI probe loci, and also with stochasti-
cally hypermethylated (FOX forkhead TF genes) and stochastically
hypomethylated (TFAP family TF genes) CGI probe loci (Table 3).
Interestingly, we also observed greater hypomethylation, in the
later generations, than in the parental cells, consistent with a
recent DNA methylation analysis of platinum-resistant ovarian
cancer [41]. At this juncture, however, we cannot ascribe any
Table 3. Enriched transcription factor genes in CGI probe loci within each of the five transgenerational methylation maintenance
categories.
Categories Enriched Transcription Factor Genes
Stochastic Hypermethylation FOXD1, FOXF2, FOXJ2, FOXL1, FOXO1, FOXO3, HNF1A, MEF2A, MEF2C, MEF2D, NKX2-5, NKX3-1, NKX6-1, NKX6-2, POU1F1, POU2F1,
POU3F2, POU6F1, SOX10, SOX11, SOX12, SOX13, SOX14, SOX15, SOX18, SOX2, SOX21, SOX3, SOX4, SOX5, SOX6, SOX8, SOX9, SRY,
STAT1, STAT5A, TBP, ZNF384
Stochastic Hypomethylation ARID5B, ASCL1, HNF4A, HNF4G, LMO2, MYF5, MYF6, MYOD1, MYOG, NFIA, NFIC, NKX2-1, NR2F1, NR2F2, NR5A1, PPARG, REST,
SMAD4, TAL1, TCF12, TCF3, TCF4, TFAP2A, TFAP2B, TFAP2C, TFAP4, TFCP2, UBP1, ZBTB6
Random Methylation REST
Heritable Low Methylation AR, ATF2, CDX2, CEBPA, CUX1, FOXD1, FOXO3, FOXO4, HMGA1, HMGA2, HNF1A, IKZF2, LEF1, LHX3, MEF2A, MEF2C, MEF2D, NFIL3,
NKX2-2, NKX2-5, NKX3-1, NKX6-1, NKX6-2, ONECUT1, ONECUT2, PAX2, PDX1, POU2F1, POU3F2, POU6F1, PRRX2, SRY, STAT4, STAT5A,
TBP, TCF7, TCF7L2, TEF, ZNF384
Heritable High Methylation AHR, ARID5B, ARNT, ASCL1, ATF1, ATF2, ATF3, ATF4, ATF7, BACH1, BACH2, BHLHB2, BHLHB3, CREB1, CREM, E2F1, E2F2, E2F3, E2F4,
E2F5, E2F7, EGR1, EGR2, EGR3, EGR4, ELF1, ELF2, ELK1, ELK4, EP300, ERF, ERG, ESR1, ESR2, ETS1, ETS2, ETV7, FLI1, GCM1, GTF2I,
HAND1, HAND2, HES1, HIF1A, HOXA5, KLF12, LMO2, MAF, MAFB, MAFF, MAFG, MAFK, MAX, MAZ, MEIS1, MITF, MTF1, MXD1, MXD4,
MXI1, MYB, MYC, MYCN, MYF5, MYF6, MYOD1, MYOG, MZF1, NFE2, NFE2L1, NFE2L2, NFE2L3, NFIA, NFIC, NHLH1, NKX2-1, NR1H2,
NR1H3, NR1I2, NR1I3, NR2F1, NR2F2, NR3C1, PATZ1, PAX5, PAX6, PGR, PPARA, RARA, RARB, RARG, REST, RUNX1, RUNX2, RUNX3,
RXRA, RXRB, RXRG, SMAD1, SMAD2, SMAD3, SMAD4, SMAD5, SMAD6, SMAD7, SMAD9, SP1, SP2, SP3, SP4, SREBF1, SREBF2, TAL1,
TAL2, TBX5, TCF12, TCF3, TCF4, TFAP2A, TFAP2B, TFAP2C, TFAP4, TFCP2, TFDP1, TFE3, TFEB, THRA, THRB, TLX2, UBP1, USF1, USF2,
VDR, YY1, ZBTB6, ZEB1, ZIC1, ZIC2, ZIC3, ZNF148
CGI microarray probe sequences were assessed for 459 human TFBS motifs from TRANSFAC using TFBS motif searching algorithm MATCH, with a significant individual
TFBS enrichment threshold determined by Fisher’s exact test and a p-value justified by Bonferroni correction of 0.05/459/5=2.261025 (i.e., p=0.05/459 TFBS motifs/
five methylation maintenance categories) when background sets were selected as #1 in Table 2.
doi:10.1371/journal.pone.0032928.t003
Table 4. Expression of genes encoding chromatin-modifying proteins that could potentially contribute to the ‘‘random’’ DNA
methylation.
Chromatin-Modifying
Genes
Fold-Change of Generation-5
Cells vs. Parental Cells (log2) Hypothesized Function
Possible influence on DNA
methylation Reference(s)
CTCF 21.28 methylation protection increase [75]
CTCFL (BORIS) 21.54 Inhibition of methylation protection decrease [38]
CXXC6 (TET1) 1.42 hydroxylation of methylcytosine likely decrease [76]
HMGB1 1.26 repressive chromatin remodeling increase [77]
DNMT3B 1.80 de novo DNA methylation increase [78]
MYST3 21.20 histone acetylation increase [79]
MYST4 21.23 histone acetylation increase [79]
doi:10.1371/journal.pone.0032928.t004
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probe loci displaying the four distinct modes of DNA methylation
maintenance.
While we did observe enhanced fidelity of DNA methylation
maintenance of CGIs enriched with TFBSs, we also noted
substantial ‘‘random’’ methylation of non-TFBS-enriched loci
(Figure 4 and Table 2). Although possibly related due to cisplatin
exposure-related DNA damage, we hypothesize that such
‘‘randomly’’ heritably methylated loci were likely mostly unasso-
ciated with cisplatin resistance, based on our definition (Table 1) of
random methylated loci as those exhibiting inconsistent methyl-
ation changes from generations 1 to 3 to 5. By contrast, CGI probe
methylation levels contributing to drug resistance (following drug
exposure) would likely, of necessity, require accurate preservation
of those methylation levels in subsequent cell generations (to allow
continued resistance) [59,60]. While likely unrelated to cisplatin
resistance, we speculate that such seemingly random methylation
could have multiple bases. One previous study demonstrated that
TFBS-unassociated CGIs recruit the Polycomb repressive com-
plex-2 (PRC2) [61], which trimethylates lysine 27 of histone H3
(H3K27me3), representing a transcription-silencing histone
‘‘mark’’ that often precedes DNA methylation. Others have
demonstrated that genes often DNA-methylated in tumors or
during normal aging are frequently development (tissue lineage)-
associated genes that copossess ‘‘bivalent’’ activating and repres-
sive histone marks in embryonic stem (ES) cells [62]. We also
observed changes in the expression of genes encoding various
chromatin modifiers (Table 4), including expression alterations
often correlated with decreased methylation, including upregula-
tion of histone acetyltransferase genes (MYST3, MYST4). Gene
expression changes that might correlate with increased DNA
methylation included downregulation of the ‘‘insulator’’ protein-
encoding gene CTCF, and upregulation of DNMT3B (encoding a
de novo DNA methyltransferase), and the CTCF antagonist gene
BORIS [24,38,55] (Table 4). Additionally as described above,
cisplatin-associated DNA damage, upon subsequent DNA repli-
cation, can result in single- or double-strand breaks, which are
now well associated with DNMT recruitment and de novo DNA
methylation [29,31,46].
Based on the strong association of CGIs with cis-acting
regulatory elements [1,13,15], we hypothesized that the methyl-
ation levels of CGIs possessing such elements might, of necessity,
be propagated in a precise manner. Consequently, we examined
the enrichment of TFBSs within CGI probe loci demonstrating the
five distinct types of methylation maintenance (Table 1), as
compared to randomly generated loci or genome-wide microarray
probes lacking TFBSs. We found that compared to random
sequences, TFBS motifs were well enriched within CGIs
comprising the four methylation maintenance categories, in
consistency with the stochastic methylation model. These results
are in strong agreement with recent studies showing that CGI
evolutionary conservation is often associated with DNA sequence
(but not GC-content) [63], representing a possible future study by
our group (i.e., the identification of sequence motifs conferring
DNA methylation fidelity).
As compared to heritably strict or stochastic DNA methylation,
however, randomly propagated CGIs (i.e., loci whose methylation
propagation was inconsistent with the stochastic model) were
completely devoid of enriched TFBSs (Tables 2). Although our
objective was not to quantify the extent of methylation variance of
specific probes categorized as random, we nevertheless noted a
large degree of variation between generations 1 to 3 that was to
some extent, reversed in generation 5 (Figure 4). We assert that
this variance was not due to technical fluctuations, a variable well
corrected for by the widely used Loess normalization [64], in
addition to our own empirically based Bayesian algorithm [39].
Although it is difficult to hypothesize a biological mechanism for
this finding, one might speculate that early chemotherapy selection
of innately resistant clones (e.g., between generations 1 and 3)
might require greater methylome and transcriptome divergence,
possibly required for the gain of tumor aggression, as compared to
(minimally aggressive) the parental (drug-naive) cells [65].
These results also agree with a previous study, of normal
epithelial cells, demonstrating that the methylation pattern error
rate (MPER) in promoter-associated unmethylated CGIs, was over
two-fold lower than the MPER of CGIs not associated with
promoter regions [10]. A similarly decreased DNA methylation
fidelity of promoter-dissociated CGIs was revealed in a study of
monozygotic and dizygotic twins [66], while the loss of a 21.8 kb
cis-regulatory element upstream of the GATA2 gene resulted in
complete loss of the maintenance of hypomethylation [67]. These
studies, and our current results, might suggest some biological
mechanism(s), yet to be identified, that preferentially enforces the
accurate fidelity of methylation levels of CGIs proximal to
regulatory elements, even in cancer cells (which are well known
to possess decreased fidelity) [5], and also in cells having genomic
instability or DNA damage (which is associated with random de
novo methylation) [29,31].
In summary, we have demonstrated non-random, heritably
strict or stochastic propagation of DNA methylation levels within
sequences possessing cis-regulatory elements, coexistent with
considerable random methylation of sequences lacking such
regulatory elements. These results support recent models of
stochastic and strict heritable DNA methylation [9,11,12,44],
while also allowing for numerous other factors that could facilitate
transient methylation states [1,13,15,61]. Further studies to
identify the existence of a possible biological mechanism(s)
underlying enhanced fidelity of methylation levels in CGIs
possessing cis-regulatory elements could provide insight into how
DNA methylation patterns are maintained, and how dysregulation
of this process could result in the inappropriate gene expression
characteristic of numerous disease pathologies.
Materials and Methods
Cell culture studies
Cell culture reagents were obtained from Invitrogen Gibco/
BRL (Carlsbad, CA). For these studies, we utilized our previously
described cell culture model system for assessing the effects of a
DNA damaging agent [47]. For these studies, we used the
cisplatin-sensitive, epithelial ovarian cancer cell line A2780
(ATCC, Manassas, VA). Starting with a single clone, drug-
sensitive parental A2780 cells were progressively exposed to
increasing doses of the DNA crosslinking agent, cisplatin [47], over
the course of five cell generations, using the cisplatin GI70 dose (i.e.,
drug dose eliciting 70% growth inhibition, as determined by
‘‘MTT dose response curves,’’ followed by normalization to
untreated cells, log transformation, and nonlinear curve fitting,
using Prism 4.0 (GraphPad, La Jolla, CA)) for each specific
generation, based on similar previous cisplatin DNA damage
studies [46,47]. Cisplatin treatments were administered for three
hours, followed by a three-day recovery period, as we have
described previously [47,68,69].
Quantitative DNA methylation microarray assessments
by differential methylation hybridization
Genomic DNA from generation-1, 3, and 5 cells was isolated
using DNeasy DNA purification kits (Qiagen, Valencia, CA). To
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bility, in the presence of possible confounding factors (such as
DNA damage, a cancer phenotype, etc.), we used a two-color
array strategy [42] previously known as differential methylation
hybridization [34,35,57,69]. Briefly, isolated DNA was digested
with the methylation-insensitive restriction enzyme BfaI (C‘TAG),
followed by ligation of linkers. Linker-ligated DNA was then
digested by the methylation-sensitive enzymes HinP1I (G‘CGC)
and HpaII (C‘CGG), and the digestion products amplified by
linker PCR. The PCR products were further amplified using
aminoallyl-dUTP incorporation labeling of the methylation-
dependent restricted DNA with the fluorophores Cy3 (green,
parental A2780) or Cy5 (red, A2780 cells after 1, 3, and 5 cell
generations [34,35,47,57,69]. The labeled DNA samples were
then combined and hybridized to a customized 60-mer oligonu-
cleotide microarray (Agilent, Santa Clara, CA) containing over
40,000 CpG-rich fragments from 12,000 known gene promoters.
Following hybridization and washing, microarrays were scanned
and images generated using an Axon GenePix 4200A scanner
(Molecular Devices, Sunnyvale, CA), with data analysis described
below. In addition, experiments were repeated with dyes swapped
for parental vs. generation 3 cells.
Differential methylation hybridization data analysis and
definitions of DNA methylation heritability patterns
Raw DMH microarray data (GenePix GPR files) were first
subjected to LOESS normalization, a method that allows
correction for background and various microarray technological
fluctuations (e.g., differences in dye intensity related to spatial
location and spot intensities), rather than biological differences
[64]. An empirical Bayesian algorithm was then used to model the
differentially methylated probes between the parental A2780 cells
(Cy3) and generation 1, 3, and 5 cells (Cy5). This model
incorporates both inter-sample variation (i.e. variation among
three control samples) and intra-sample variations (i.e., probe-
specific pixel variations in foreground and background signals)
[39], with all random variables modeled by normal distributions.
Differentially methylated probes were determined by their
empirical Bayesian probabilities, using a probability threshold of
0.80. All DMH DNA methylation data has been deposited, in
MIAME format, in the Gene Expression Omnibus (http://www.
ncbi.nlm.nih.gov/projects/geo/; accessible using SuperSeries
code GSE15709).
By comparing the parental A2780 with their 1
st,3
rd,a n d5
th
generation progeny cells, CGI microarray probes having
increased methylation (probability$0.80 by the empirical
Bayesian algorithm) were defined as hypermethylated, while
probes with decreased methylation (probability$0.80) were
defined as hypomethylated; otherwise, the methylation status of
CGI probes was considered unchanged. As described in Table 1,
our results yielded four possible patterns of transgenerational
maintenance of DNA methylation, in accord with the stochastic
model of Riggs et al., which allows for highly or lowly
methylated loci to ultimately achieve similar steady states of
DNA methylation, due to fluctuations in the efficiency of
methylation maintenance and/or de novo DNA methyltransferase
activity [11,12]. Consequently, CGI probes showing progres-
sively increased methylation from generations 1 to 5 were
defined as stochastically hypermethylated, while probes showing
progressively decreased methylation were defined as stochastically
hypomethylated (Table 1). Among CGI probes showing no change
in methylation (probability ,0.80 by the empirical Bayesian
algorithm), those showing consistently high methylation (.85%
of the maximal microarray fluorescence, regardless of genera-
tion, also having #15% changes between generations) were
designated as heritably highly methylated. By contrast, CGI
microarray consistently having ,15% of the maximal fluores-
cence (regardless of cell generation, also having #15% changes
between generations) were categorized as heritably lowly methyl-
ated. Both heritably high and low methylated loci were consistent
with the faithful DNA maintenance mechanism of Riggs’ model
[11,12]. Finally, probes demonstrating a mixture of increased
a n dd e c r e a s e dm e t h y l a t i o nf r o mg e n e r a t i o n s1t o5w e r e
assigned to a fifth category, random methylation (Table 1), a
condition not described by the stochastic methylation mainte-
nance model of Riggs et al.[ 1 1 , 1 2 ] .
Analysis of the behavior of adjacent CGI probe loci
As adjacent probes, we chose those probes located in the same
genes and within a distance of 1500 bp as being adjacent, as
more than 90% of CGIs have length less than 1500 bp [70].
Thus, all the probes were clustered into a number of different
clusters, with probes in the same cluster are adjacent to each
other and probes in different clusters are not adjacent. As a result,
probes from the same CGI are resided in the same cluster. If all
the probes localized in the same cluster fall into the same
category, the CGI represented by that cluster is in a consistent
methylation heritability status; otherwise, the CGI should has
multiple statuses.
Gene expression microarrays
For gene expression analyses, total RNA was isolated from
parental and fifth generation A2780 cells using RNeasy purifica-
tion kits (Qiagen, Valencia, CA), reverse transcribed to cDNA,
followed by in vitro transcription to biotinylated cRNA, purifica-
tion, and labeling for hybridization, using our previously described
method [47,57]. All microarray hybridizations were performed in
quadruplicate for each A2780 cell generation using Human U133
plus 2.0 GeneChips (Affymetrix, Santa Clara, CA), and is
deposited in NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/projects/geo/), accessible through GEO
SuperSeries GSE15709).
In addition to the assessment of propagation of DNA
methylation patterns, another objective was to determine time-
dependent and cell division-dependent changes in gene expression,
using microarray profiling (Affymetrix) of fifth-generation total
cellular mRNA, as compared to total RNA derived from the
parental cell line. Using Bioconductor [71], present (P), absent (A)
or marginal (M) calls were determined using an Affymetrix Micro
Array Suite 5.0 (MS 5.0) algorithm [72]. Fraction presence,
defined as the average present/absent (P/A) detection call (scores
assigned as P=1, M=0.5 and A=0) for the experimental or
control groups, was calculated for each microarray probe, and
probes with at least one group having a fraction presence of 0.5
were selected for future use. Welch’s t-tests were determined for
each probe using its log-transformed signal, with p-values,0.01
considered significant. To further support the statistical signifi-
cance of probes having p,0.01, we applied a moderately stringent
fold-change cutoff of $1.2 or #21.2 for downregulation (thus
allowing an acceptable balance between false discovery and false
negative rates) [73], in addition to the p-value cutoffs, to determine
genes showing significant expression changes.
Subsequent to the categorization of CGI probes into the five
methylation maintenance categories (described above and in
Table 1), to determine possible causes of our observed of
‘‘random’’ methylation, we examined the expression of various
chromatin-regulating genes, in fifth vs. parental generation cells.
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sites (TFBSs) within CpG islands (CGIs)
We used our previously reported method [17] to identify TFBSs
within the microarray (Agilent) CGI probe sequences included in
any of the five methylation maintenance categories. TFBS
searching was performed using MATCH algorithm (http://
www.bioinfo.de/isb/gcb01/poster/goessling.html) [58], a weight
matrix-based software. Two background sequence sets were
selected, with the first background sequence set containing
randomly generated promoter sequences matched (to the
categorized probes) for equal length and GC content, while the
second background probe set was generated by random selection
of all CGI microarray CGI probe sequences not falling into any of
the five methylation categories (i.e, not meeting any of the
methylation pattern criteria shown in Table 1), but retaining the
same GC content and sequence length. The frequencies of the
predicted TFBSs for each probe within the five methylation
maintenance categories (Table 1), and background sequences,
were then compared by Fisher’s exact test. Bonferroni justification
was implemented to justify 459 human transcription factor motifs,
i.e., an individual p-value threshold was chosen as 0.05/459/
5=2.2610
25, for multiple comparisons [74].
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